| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Roscovitine | GDSC1000 | pan-cancer | AAC | -0.093 | 0.08 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.058 | 0.08 |
| mRNA | CGP-082996 | GDSC1000 | pan-cancer | AAC | -0.092 | 0.08 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | 0.058 | 0.09 |
| mRNA | Bryostatin 1 | GDSC1000 | pan-cancer | AAC | -0.063 | 0.09 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | 0.059 | 0.09 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.09 |
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.09 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | 0.065 | 0.09 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | 0.069 | 0.09 |